1-甲基环己烷-1-腈 | 62718-34-7

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 1-甲基环己烷-1-腈
• 英文名称: 1-Methylcyclohexacarbonitrile
• 英文别名: 1-methylcyclohexanecarbonitrile；1-Methylcyclohexylnitril；1-Methyl-cyan-cyclohexan；1-Methyl-cyclohexancarbonitril；1-methylcyclohexylcarbonitrile；1-Methylcyclohexane-1-carbonitrile
• CAS: 62718-34-7
• 化学式: C₈H₁₃N
• mdl: MFCD13180546
• 分子量: 123.198
• InChiKey: KYVFVCXSNCUBTI-UHFFFAOYSA-N

物化性质

• 沸点：
  181-182 °C
• 密度：
  0.90±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  23.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-甲基环己烷-1-腈 在 氢氧化钾 作用下， 生成 1-甲基环己烷羧酸
  参考文献：
  名称：

  Tarbouriech, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences, 1910, vol. 150, p. 1606

  摘要：

  DOI：
• 作为产物：
  描述：

  1-羟基甲基-1-甲基环己烷 在 2,2,6,6-四甲基哌啶氧化物 、 1,3-二碘-5,5-二甲基海因 、 氨 、 碘 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 4.0h， 以99%的产率得到1-甲基环己烷-1-腈
  参考文献：
  名称：

  Simple One-Pot Conversion of Alcohols into Nitriles

  摘要：

  Various benzylic and primary alcohols were efficiently converted into the corresponding nitriles in good yields at room temperature by treatment with tert-butyl hypochlorite, diiodine, or 1,3-diiodo-5,5-dimethylhydantoin in the presence of (2,2,6,6-tetramethylpiperidin-1-yl) oxidanyl (TEMPO), followed by treatment with diiodine and aqueous ammonia. The nitriles were obtained in good yields and high purities simply by extraction of the reaction mixture with chloroform and subsequent removal of the solvent.

  DOI：

  10.1055/s-0033-1338489

文献信息

• [EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA REPLICATION DU VIRUS DE L'IMMUNODEFICIENCE HUMAINE
  申请人：BOEHRINGER INGELHEIM INT

  公开号：WO2010130034A1

  公开（公告）日：2010-11-18

  Compounds of formula I wherein a, R1, R2, R3, R4, R5 and R6 are defined herein, are useful as inhibitors of HIV replication.

  式I中的化合物，其中a、R1、R2、R3、R4、R5和R6如本文所定义，可用作HIV复制抑制剂。
• [EN] ATR INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'ATR ET LEURS UTILISATIONS
  申请人：SHANGHAI ANTENGENE CORPORATION LTD

  公开号：WO2022002245A1

  公开（公告）日：2022-01-06

  The present disclosure relates to novel compounds useful as inhibitors of ATR kinase, as well as pharmaceutical compositions comprising these compounds and methods of treatment by administration of these compounds or the pharmaceutical compositions.

  本公开涉及作为ATR激酶抑制剂有用的新化合物，以及包含这些化合物的药物组合物和通过给予这些化合物或药物组合物进行治疗的方法。
• Trimethylsilyl cyanide promoted cyanation of tertiary alkyl chlorides and other SN1 active compounds
  作者：Manfred T. Reetz、Ioannis Chatziiosifidis、Hermann Künzer、Hans Müller-Starke

  DOI：10.1016/s0040-4020(01)88594-x

  日期：1983.1

  Tertiary chlorides are readily cyanated in a one-pot procedure using trimethylsilyl cyanide in the presence of SnCl4. The mechanism of this novel and synthetically useful reaction involves initial isonitrile formation followed by rearrangement to the tertiary nitrile. Other SN1 active componds also undergo smooth cyanation.

  在存在SnCl 4的情况下，使用三甲基甲硅烷基氰化物可以在一锅法中轻易地将氯化叔氰化。这种新颖的，合成上有用的反应的机理包括最初形成异腈，然后重排成叔腈。其他s Ñ 1活性componds也经历平滑氰化。
• AMIDE COMPOUND AND USE THEREOF
  申请人：Sumitomo Chemical Company, Limited

  公开号：EP2151431A1

  公开（公告）日：2010-02-10

  Disclosed is an amide compound represented by the formula (1) below, which has excellent plant disease controlling activity. In the formula, X1 represents a fluorine atom or a methoxy group; X2 represents a chlorine atom, a bromine atom, an iodine atom, a C1-C4 alkyl group or the like; Z represents an oxygen atom or a sulfur atom; and A represents an A1-CR11R12R13 group or A2-Cy group, wherein A1 and A2 each represents a single bond or the like, R11 and R12 independently represent a C1-C4 alkyl group, R13 represents H, a C1-C4 alkyl group or the like, and Cy represents a C3-C6 cycloalkyl group or the like.

  本发明公开了一种酰胺化合物，其化学式如下（1），具有出色的植物病害控制活性。在该式中，X1代表氟原子或甲氧基；X2代表氯原子、溴原子、碘原子、C1-C4烷基或类似物；Z代表氧原子或硫原子；A代表A1-CR11R12R13基团或A2-Cy基团，其中A1和A2各代表单键或类似物，R11和R12分别独立地代表C1-C4烷基，R13代表H、C1-C4烷基或类似物，Cy代表C3-C6环烷基或类似物。
• PYRAZOLO[1,5-A] PYRIMIDINE COMPOUNDS AS CB1 RECEPTOR ANTAGONIST
  申请人：Tanimoto Koichi

  公开号：US20090258867A1

  公开（公告）日：2009-10-15

  The present invention provides a pyrazolo[1,5-a]pyrimidine compound, having CB1 receptor-antagonizing activity, of the following formula [I]: in which R 1 and R 2 are the same or different and each an optionally substituted aryl group etc, R 0 is hydrogen atom, an alkyl group etc, E is a group of the formula: —C(═O)— or —SO 2 —, R is a group of the following formula [i], [ii] or [iii] etc: Ring A is (a) a C 3-8 cycloalkyl group optionally fused to a benzene ring or (b) a benzene ring, Q is a single bond or a methylene group, Ring B is a 4- to 7-membered aliphatic heterocyclic group, said cyclic group binding via its ring-carbon atom to the adjacent nitrogen atom, X is sulfur atom etc, R 3 is an alkyl group optionally substituted by an alkylthio group, R 4 is hydrogen atom, an alkyl group etc, one of R A and R B is an alkyl group etc, and the other is hydrogen atom, an alkyl group etc, or a pharmaceutically acceptable salt thereof.

  本发明提供了一种具有CB1受体拮抗活性的吡唑并[1,5-a]嘧啶化合物，其化学式[I]如下：其中，R1和R2相同或不同，分别是可选取代的芳基等；R0是氢原子，烷基等；E是以下式子的基团：—C(═O)—或—SO2—；R是以下式子[i]、[ii]或[iii]等的基团：环A是(a)一个C3-8环烷基，可选地融合到苯环上，或(b)一个苯环；Q是单键或亚甲基基团；环B是一个4-7个成员的脂肪族杂环基团，该环基团通过其环碳原子与相邻的氮原子结合；X是硫原子等；R3是可选取代的烷基，可以是烷基硫基等；R4是氢原子，烷基等；RA和RB中的一个是烷基等，另一个是氢原子，烷基等，或其药学上可接受的盐。